Summary
Updated Aug 31, 2026
BROADWOOD PARTNERS, L.P. is 10% Owner of Insight Molecular Diagnostics Inc. (IMDX). 12 SEC Form 4 filings on record going back to 2024, most recently on 27 April 2026. Most recent open-market trade: bought $913K of IMDX on 27 April 2026. Lifetime open-market purchases: $91.70M. Historical track record: 5/5 stars across 34 tracked purchases.
Recent Transactions
20Every recent SEC Form 4 transaction BROADWOOD PARTNERS, L.P. has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 34 |
| Purchases with forward-return data | 33 |
| 30-day win rate | 61% |
| 90-day win rate | 58% |
| Avg 5-day return | +0.80% |
| Avg 30-day return | +16.85% |
| Avg 90-day return | +4.74% |
| Best 30-day return | +82.95% |
Trading Pattern
InsiderAlpha's records for BROADWOOD PARTNERS, L.P. go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. The typical open-market purchase is $1.35M (68 buys totaling $91.70M). The largest single buy on record is $22.22M of STAA in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as BROADWOOD PARTNERS, L.P.. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Patrick W. Smith - $192K of IMDX open-market activity on record
- Andrea S. James - $146K of IMDX open-market activity on record
- Andrew Arno - $26K of IMDX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is BROADWOOD PARTNERS, L.P.?
BROADWOOD PARTNERS, L.P. is an investment firm, tracked as 10% Owner of Insight Molecular Diagnostics Inc. (IMDX). InsiderAlpha holds 12 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did BROADWOOD PARTNERS, L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 27 April 2026, one of 12 filings going back to 2024.
Has BROADWOOD PARTNERS, L.P. been buying or selling stock?
Recorded transactions: 68 open-market purchases ($91.70M) and 0 open-market sales across all tracked filings.
How accurate is BROADWOOD PARTNERS, L.P.'s historical track record?
Across 34 tracked purchases, BROADWOOD PARTNERS, L.P. averaged +16.8% avg 30-day return with a 61% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of BROADWOOD PARTNERS, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow BROADWOOD PARTNERS, L.P. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial